AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 63 filers reported holding AKCEA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,191,000 | -35.7% | 70,286 | -41.6% | 0.05% | -37.5% |
| Q3 2019 | $1,851,000 | -34.4% | 120,286 | 0.0% | 0.08% | -38.9% |
| Q2 2019 | $2,821,000 | +98.0% | 120,286 | +139.2% | 0.13% | +98.5% |
| Q1 2019 | $1,425,000 | -37.2% | 50,286 | -33.2% | 0.07% | -39.4% |
| Q4 2018 | $2,269,000 | -32.0% | 75,286 | -21.0% | 0.11% | -27.8% |
| Q3 2018 | $3,337,000 | -28.8% | 95,286 | -51.8% | 0.15% | -18.4% |
| Q2 2018 | $4,690,000 | -2.5% | 197,800 | +5.3% | 0.18% | -4.6% |
| Q1 2018 | $4,810,000 | +84.7% | 187,800 | +25.2% | 0.19% | +94.0% |
| Q4 2017 | $2,604,000 | -24.7% | 150,000 | +20.0% | 0.10% | -23.7% |
| Q3 2017 | $3,459,000 | – | 125,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |